Praxis Precision Medicines, Inc. / Fundamentals
Income statement
- Net revenue
€6.66M - Cost of goods sold
€79.79K - Gross profit
€6.58M - SG&A expenses
€49.18M - R&D expenses
€190.46M - EBITDA
-€228.58M - D&A
€199.06K - EBIT
-€233.02M - Interest expenses
€0.00 - EBT
-€215.37M - Tax expenses
€0.00 - Net income
-€215.37M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€29.90M - Changes in working capital
-€6.09M - Operating cash flow
-€164.14M - Capex
€48.05K - Other investing cash flow
€0.00 - Net investing cash flow
€4.70M - Total cash dividends paid
€0.00 - Issuance of common stock
€97.11M - Debt repayment
€716.43K - Other financing cash flow
€72.14M - Net financing cash flow
€169.97M - Foreign exchange effects
€0.00 - Net change in cash
€10.53M - Cash at end of period
€135.42M - Free cash flow
-€164.09M
Balance sheet
- Cash and cash equivalents
€135.06M - Cash and short-term investments
€258.49M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€4.55M - Total current assets
€263.05M - Property, plant & equipment
€758.47K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€124.73M - Other non-current assets
€0.00 - Total non-current assets
€125.49M - Total assets
€388.53M - Accounts payable
€24.74M - Short-term debt
€647.79K - Other current liabilities
€16.32M - Total current liabilities
€41.71M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€0.00 - Total liabilities
€41.71M - Common stock
€12.01K - Retained earnings
-€838.41M - Other equity
€338.91K - Total equity
€346.82M - Total liabilities and shareholders' equity
€388.53M
Company information
- Market capitalization
€747.07M - Employees
116 - Enterprise Value
€743.85M
Company ratios
- Gross margin
-
98.8% Much better than peer group: -113,231,243,252,760.2% - EBITDA margin
-
-3,431.0% Much better than peer group: -622,621,262,285,643.4% - EBIT margin
-
-3,497.6% Much better than peer group: -628,433,688,453,528.2% - EBT margin
-
-3,232.6% Much better than peer group: -627,687,940,194,854.1% - Net margin
-
-3,232.6% Much better than peer group: -627,687,940,191,162.6% - ROE
-
-62.1% Much worse than peer group: 240.2% - ROA
-
-55.4% Even with peer group: -52.8% - Asset turnover
-
1.7% Worse than peer group: 17.8% - FCF margin
-
-2,464.4% Much better than peer group: -523,001,454,953,398.3% - FCF yield
-22.0% - Efficiency ratio
3,531.0% - Net sales per employee
-
€57.43K - Net income per employee
-
-€1.86M